These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8807116)

  • 1. The effect of hydroxychloroquine on alloreactivity and its potential use for graft-versus-host disease.
    Gilman AL; Beams F; Tefft M; Mazumder A
    Bone Marrow Transplant; 1996 Jun; 17(6):1069-75. PubMed ID: 8807116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation.
    Khoury H; Trinkaus K; Zhang MJ; Adkins D; Brown R; Vij R; Goodnough LT; Ma MK; McLeod HL; Shenoy S; Horowitz M; Dipersio JF
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):714-21. PubMed ID: 14652855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous protein antigen, tetanus toxoid.
    Schultz KR; Nelson D; Bader S
    Bone Marrow Transplant; 1996 Sep; 18(3):625-31. PubMed ID: 8879628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation.
    Fong T; Trinkaus K; Adkins D; Vij R; Devine SM; Tomasson M; Goodnough LT; Lopez S; Graubert T; Shenoy S; Dipersio JF; Khoury HJ
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1201-6. PubMed ID: 17889357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
    J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine for the treatment of chronic graft-versus-host disease.
    Gilman AL; Chan KW; Mogul A; Morris C; Goldman FD; Boyer M; Cirenza E; Mazumder A; Gehan E; Cahill R; Frankel S; Schultz K
    Biol Blood Marrow Transplant; 2000; 6(3A):327-34. PubMed ID: 10905770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?
    Schultz KR; Bader S; Nelson D; Wang MD; HayGlass KT
    Transplantation; 1997 Oct; 64(7):1055-65. PubMed ID: 9381529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin-15 on alloreactivity in umbilical cord blood.
    Lin SJ; Cheng PJ; Yan DC; Lee PT; Hsaio HS
    Transpl Immunol; 2006 Aug; 16(2):112-6. PubMed ID: 16860714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
    Georgantas RW; Bohana-Kashtan O; Civin CI
    Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolytic effector mechanisms and gene expression in autologous graft-versus-host disease: distinct roles of perforin and Fas ligand.
    Miura Y; Thoburn CJ; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Mar; 10(3):156-70. PubMed ID: 14993881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine IL-10 fails to reduce GVHD despite inhibition of alloreactivity in vitro.
    Emmanouilides CE; Luo J; Baldwin G; Buckley D; Lau P; Lopez E; Tabibzadeh S; Yu J; Wolin M; Rigor R; Territo M; Black AC
    Bone Marrow Transplant; 1996 Aug; 18(2):369-75. PubMed ID: 8864448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocamouflage: prevention of transfusion-induced graft-versus-host disease via polymer grafting of donor cells.
    Chen AM; Scott MD
    J Biomed Mater Res A; 2003 Nov; 67(2):626-36. PubMed ID: 14566806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1.
    Leng C; Gries M; Ziegler J; Lokshin A; Mascagni P; Lentzsch S; Mapara MY
    Exp Hematol; 2006 Jun; 34(6):776-87. PubMed ID: 16728283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected T-cell diversity in syngeneic graft-versus-host disease revealed by interaction with peptide-loaded soluble MHC class II molecules.
    Hess AD; Thoburn CJ; Chen W; Bright AE
    Transplantation; 2003 Apr; 75(8):1361-7. PubMed ID: 12717231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for mesenchymal stem cells in the control of graft-versus-host disease.
    Cohen JL; Sudres M
    Transplantation; 2009 May; 87(9 Suppl):S53-4. PubMed ID: 19424007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional divergence of antigen-specific T-lymphocyte responses in syngeneic graft-versus-host disease.
    Thoburn CJ; Miura Y; Bright EC; Hess AD
    Biol Blood Marrow Transplant; 2004 Sep; 10(9):591-603. PubMed ID: 15319771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.